Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m²
Annals of Transplantation · 2025
DOI: 10.12659/aot.947186 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Transplantation, 2025. Verfasst von Umut Yılmaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiple Myeloma, Melphalan, Myeloablative Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
- Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
ORCID-Profile: Umut Yılmaz, Şükran Erdem Nurcan, Deniz Özmen, Teoman Soysal
Zitieren
APA
Yılmaz, U., Erdem Nurcan, Ş., Özmen, D., Salihoğlu, A., Eşkazan, A. E., Öngören, Ş., Başlar, Z., Soysal, T., Ar, M. C., & Elverdi, T. (2025). Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m². Annals of Transplantation. https://doi.org/10.12659/aot.947186
Vancouver
Yılmaz U, Erdem Nurcan Ş, Özmen D, Salihoğlu A, Eşkazan AE, Öngören Ş, et al. Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m². Annals of Transplantation. 2025. doi:10.12659/aot.947186
BibTeX
@article{Ylmaz2025,
author = {Yılmaz, Umut and Erdem Nurcan, Şükran and Özmen, Deniz and Salihoğlu, Ayşe and Eşkazan, Ahmet Emre and Öngören, Şeniz and Başlar, Zafer and Soysal, Teoman and Ar, Muhlis Cem and Elverdi, Tuğrul},
title = {Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m²},
journal = {Annals of Transplantation},
year = {2025},
doi = {10.12659/aot.947186}
}
EUVIMED